We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.06%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$75.4B
AUM Growth
-$3.33B
(-4.2%)
Cap. Flow
-$1.58B
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
1,814
New
77
Increased
635
Reduced
934
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$241M |
| 2 |
Kraft Heinz
KHC
|
+$207M |
| 3 |
Apple
AAPL
|
+$196M |
| 4 |
Targa Resources
TRGP
|
+$152M |
| 5 |
Progressive
PGR
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$573M |
| 2 |
ICICI Bank
IBN
|
+$231M |
| 3 |
Mercado Libre
MELI
|
+$210M |
| 4 |
Visa
V
|
+$206M |
| 5 |
JPMorgan Chase
JPM
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.14% |
| 2 | Consumer Discretionary | 13.35% |
| 3 | Energy | 12.59% |
| 4 | Healthcare | 11.74% |
| 5 | Communication Services | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
501
DELISTED
Sage Therapeutics
SAGE
| $24M | 0.03% |
+749,566
| New | +$26.4M |
|
|
CLVS
502
DELISTED
Clovis Oncology, Inc.
CLVS
| $23.9M | 0.03% |
1,246,660
+1,150
| +0.1% | +$24.3K |
|
503
Aecom
ACM
$9.07B
| $23.8M | 0.03% |
773,987
+53,312
| +7% | +$1.48M |
|
504
Tyson Foods
TSN
$20.2B
| $23.8M | 0.03% |
356,755
+29,558
| +9% | +$1.78M |
|
|
SKX
505
DELISTED
Skechers
SKX
| $23.7M | 0.03% |
779,027
-166,461
| -18% | -$5.01M |
|
|
CY
506
DELISTED
Cypress Semiconductor
CY
| $23.7M | 0.03% |
2,738,559
+234,992
| +9% | +$1.9M |
|
507
Associated Banc-Corp
ASB
$5.81B
| $23.3M | 0.03% |
1,298,652
-11,158
| -0.9% | -$195K |
|
508
Celanese
CE
$5.09B
| $23.3M | 0.03% |
354,993
+47,560
| +15% | +$2.95M |
|
|
MEP
509
DELISTED
Midcoast Energy Partners, L.P.
MEP
| $23.1M | 0.03% |
4,499,321
+6,160
| +0.1% | +$37K |
|
510
HealthEquity
HQY
$7.91B
| $23.1M | 0.03% |
935,398
+210,860
| +29% | +$4.52M |
|
|
USCR
511
DELISTED
U S Concrete, Inc.
USCR
| $23.1M | 0.03% |
386,969
+33,562
| +9% | +$1.71M |
|
|
NSA
512
DELISTED
National Storage Affiliates Trust
NSA
| $23M | 0.03% |
1,084,467
-173,881
| -14% | -$3.12M |
|
|
ENH
513
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $23M | 0.03% |
351,863
+44,166
| +14% | +$2.76M |
|
514
Icon
ICLR
$12.8B
| $22.9M | 0.03% |
305,196
+20,780
| +7% | +$1.46M |
|
|
HOLX
515
DELISTED
Hologic
HOLX
| $22.9M | 0.03% |
662,884
-49,114
| -7% | -$1.71M |
|
|
DPLO
516
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $22.7M | 0.03% |
830,114
-398,493
| -32% | -$11.7M |
|
517
T-Mobile US
TMUS
$193B
| $22.7M | 0.03% |
593,245
+20,850
| +4% | +$787K |
|
518
Liberty Global Class A
LBTYA
$3.31B
| $22.6M | 0.03% |
673,886
+63,282
| +10% | +$1.99M |
|
|
SONC
519
DELISTED
Sonic Corp
SONC
| $22.6M | 0.03% |
642,788
+632,967
| +6,445% | +$18.9M |
|
|
LNCE
520
DELISTED
Snyders-Lance, Inc.
LNCE
| $22.5M | 0.03% |
716,090
+97,121
| +16% | +$3.11M |
|
521
CMS Energy
CMS
$23.1B
| $22.3M | 0.03% |
525,402
+47,640
| +10% | +$1.87M |
|
|
EMC
522
DELISTED
EMC CORPORATION
EMC
| $22.2M | 0.03% |
834,432
-38,165
| -4% | -$967K |
|
523
SL Green Realty
SLG
$3.88B
| $22.1M | 0.03% |
+235,410
| New | +$21.5M |
|
524
Oneok
OKE
$58.7B
| $22.1M | 0.03% |
739,251
-24,749
| -3% | -$609K |
|
|
PXD
525
DELISTED
Pioneer Natural Resource Co.
PXD
| $22M | 0.03% |
156,260
-58,723
| -27% | -$7.28M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2016 Portfolio in Review
As of Q1 2016, OppenheimerFunds held 1,814 positions worth $75.4B, down 4.2% from $78.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q1 2016 filing shows 77 new, 635 increased, 934 reduced and 133 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,497,249 shares worth $122M. The largest sale was Gilead Sciences, an estimated $573M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Energy.
- OppenheimerFunds's largest Q1 2016 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,497,249 shares worth $122M.
- OppenheimerFunds added most to McDonald's in Q1 2016, an estimated $241M increase.
- OppenheimerFunds's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $573M.
- OppenheimerFunds fully exited Mercado Libre in Q1 2016, selling an estimated $210M.
- OppenheimerFunds's ten largest holdings make up 14% of its $75.4B portfolio in Q1 2016.
- OppenheimerFunds opened 77 new positions and closed 133 in Q1 2016.
- OppenheimerFunds's portfolio value fell 4.2% quarter-over-quarter to $75.4B.
Based on OppenheimerFunds's 13F filing for Q1 2016, filed 12 May 2016.